Evaluation_NN
of_IN
the_DT
role_NN
of_IN
ligand_NN
and_CC
thermal_JJ
activation_NN
of_IN
specific_JJ
DNA_NN
binding_NN
by_IN
in_FW
vitro_FW
synthesized_VBN
human_JJ
glucocorticoid_NN
receptor_NN
._.

We_PRP
have_VBP
used_VBN
a_DT
DNA-binding\/immunoprecipitation_JJ
assay_NN
to_TO
analyze_VB
the_DT
capacity_NN
of_IN
human_JJ
glucocorticoid_NN
receptor_NN
-LRB-_-LRB-
hGR_NN
-RRB-_-RRB-
,_,
generated_VBN
in_IN
rabbit_NN
reticulocyte_NN
lysates_NNS
,_,
to_TO
bind_VB
DNA_NN
._.

In_FW
vitro_FW
translated_VBN
hGR_NN
was_VBD
indistinguishable_JJ
from_IN
native_JJ
hGR_NN
,_,
as_IN
determined_VBN
by_IN
migration_NN
on_IN
sodium_NN
dodecyl_NN
sulfate-polyacrylamide_JJ
gels_NNS
,_,
sedimentation_NN
on_IN
sucrose_NN
density_NN
gradients_NNS
,_,
and_CC
reactivity_NN
with_IN
antipeptide_JJ
antibodies_NNS
generated_VBN
against_IN
hGR_NN
._.

In_IN
addition_NN
,_,
cell-free_JJ
synthesized_VBN
hGR_NN
was_VBD
capable_JJ
of_IN
specific_JJ
binding_NN
to_TO
glucocorticoid_NN
response_NN
element_NN
-LRB-_-LRB-
GRE_NN
-RRB-_-RRB-
-_:
containing_VBG
DNA_NN
fragments_NNS
._.

Using_VBG
this_DT
assay_NN
system_NN
,_,
we_PRP
have_VBP
evaluated_VBN
the_DT
contributions_NNS
of_IN
ligand_NN
binding_NN
and_CC
heat_NN
activation_NN
to_TO
DNA_NN
binding_VBG
by_IN
these_DT
glucocorticoid_NN
receptors_NNS
._.

In_FW
vitro_FW
translated_VBN
hGR_NN
was_VBD
capable_JJ
of_IN
selective_JJ
DNA_NN
binding_NN
even_RB
in_IN
the_DT
absence_NN
of_IN
glucocorticoid_NN
._.

Treatment_NN
with_IN
dexamethasone_NN
or_CC
the_DT
antiglucocorticoid_JJ
RU486_NN
had_VBD
no_DT
additional_JJ
effect_NN
on_IN
the_DT
DNA-binding_JJ
capacity_NN
when_WRB
receptor_NN
preparations_NNS
were_VBD
maintained_VBN
at_IN
0_CD
C_NN
-LRB-_-LRB-
no_DT
activation_NN
-RRB-_-RRB-
._.

In_IN
contrast_NN
,_,
addition_NN
of_IN
either_CC
ligand_NN
or_CC
antagonist_NN
in_IN
combination_NN
with_IN
a_DT
heat_NN
activation_NN
step_NN
promoted_VBD
DNA_NN
binding_NN
by_IN
approximately_RB
3-fold_JJ
over_IN
that_DT
of_IN
heat-activated_JJ
unliganded_JJ
receptors_NNS
._.

Agonist_NN
-LRB-_-LRB-
dexamethasone_NN
-RRB-_-RRB-
was_VBD
slightly_RB
more_RBR
effective_JJ
in_IN
supporting_VBG
specific_JJ
DNA_NN
binding_NN
than_IN
antagonist_NN
-LRB-_-LRB-
RU486_NN
-RRB-_-RRB-
._.

DNA_NN
binding_NN
by_IN
in_FW
vitro_FW
synthesized_VBN
GR_NN
was_VBD
blocked_VBN
by_IN
the_DT
addition_NN
of_IN
sodium_NN
molybdate_NN
to_TO
the_DT
receptor_NN
preparations_NNS
before_IN
steroid_NN
addition_NN
and_CC
thermal_JJ
activation_NN
._.

Addition_NN
of_IN
KCl_NN
resulted_VBD
in_IN
less_RBR
DNA_NN
binding_NN
either_CC
due_JJ
to_TO
blockage_NN
of_IN
DNA-receptor_JJ
complex_NN
formation_NN
or_CC
disruption_NN
of_IN
the_DT
complexes_NNS
._.

The_DT
specificity_NN
of_IN
DNA_NN
binding_NN
by_IN
cell-free_JJ
synthesized_VBN
hGR_NN
was_VBD
analyzed_VBN
further_RB
by_IN
examining_VBG
the_DT
abilities_NNS
of_IN
various_JJ
DNAs_NNS
to_TO
compete_VB
for_IN
binding_NN
to_TO
a_DT
naturally_RB
occurring_VBG
GRE_NN
found_VBN
in_IN
the_DT
mouse_NN
mammary_JJ
tumor_NN
virus-long_JJ
terminal_JJ
repeat_NN
._.

Oligonucleotides_NNS
containing_VBG
the_DT
consensus_NN
GRE_NN
were_VBD
the_DT
most_RBS
efficient_JJ
competitors_NNS
,_,
and_CC
fragments_NNS
containing_VBG
regulatory_JJ
sequences_NNS
from_IN
glucocorticoid-repressible_JJ
genes_NNS
were_VBD
somewhat_RB
competitive_JJ
,_,
whereas_IN
single_JJ
stranded_JJ
oligonucleotides_NNS
were_VBD
unable_JJ
to_TO
compete_VB
for_IN
mouse_NN
mammary_JJ
tumor_NN
virus-long_JJ
terminal_JJ
repeat_NN
DNA_NN
binding_NN
,_,
except_IN
when_WRB
competitor_NN
was_VBD
present_JJ
at_IN
extremely_RB
high_JJ
concentrations_NNS
._.

Together_RB
these_DT
studies_NNS
indicate_VBP
that_IN
hGR_NN
synthesized_VBN
in_IN
rabbit_NN
reticulocyte_NN
lysates_NNS
displays_VBZ
many_JJ
of_IN
the_DT
same_JJ
properties_NNS
,_,
including_VBG
GRE-specific_JJ
DNA_NN
binding_NN
,_,
observed_VBN
for_IN
glucocorticoid_NN
receptor_NN
present_JJ
in_IN
cytosolic_JJ
extracts_NNS
of_IN
mammalian_JJ
cells_NNS
and_CC
tissues_NNS
._.

Similarities_NNS
between_IN
the_DT
effects_NNS
of_IN
dexamethasone_NN
and_CC
RU486_NN
suggest_VBP
that_IN
the_DT
antiglucocorticoid_JJ
properties_NNS
of_IN
RU486_NN
do_VBP
not_RB
occur_VB
at_IN
the_DT
level_NN
of_IN
specific_JJ
DNA_NN
binding_NN
._.

